Ceren Ozek’s postdoctoral research in the Rubin Lab focuses on the beneficial vascular and neural effects of GDF11 on healthy aging and neurodegenerative diseases, specifically Alzheimer’s Disease, using transgenic mice as model organisms. She collaborates with other members of the lab and with colleagues at Columbia University and University of Sao Paolo, researching changes in the brain vasculature.
Ceren has been a teaching fellow for the department’s undergraduate Neurobiology of Behavior course. She obtained her Ph.D. in neuroscience from the University of Pennsylvania, working in the lab of Dr Kendra Bence.